Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. Doctors say it can be extremely ...
In many incretin-based interventions, reductions in muscle-related indices exceed prespecified benchmarks, according to a review published online April 17 in th ...
GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...
High doses of the dual agonist tirzepatide appear to provide greater weight loss than other GLP-1s among adults with ...
Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to ...
Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight. “At this time, there is no other medication like ...
MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...
Weight loss injections are considered safe and effective for most people with obesity or excess weight. Still, like all medications, they can cause unwanted side effects — like nausea, constipation, ...
Discover the top 10 weight loss medications of 2026. Explore how advanced GLP-1 therapies and combination drugs are reshaping ...
5don MSN
Is erectile dysfunction a side effect of taking weight-loss drugs? New trial results say yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results